Showing results (81-90 of 708) with videos related to
Sort By:
Pageof 71
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 9, 2011
The Vienna protocol and perspectives in radionuclide therapyH Sinzinger, B Palumbo, K OzkerVASA. Supplementum|January 1, 1989
Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)--an updateH Sinzinger, I Virgolini, P FitschaWiener Klinische Wochenschrift|February 21, 1986
[Vasodilating effect of leukotriene C4 and D4 by stimulation of prostacyclin synthesis]H Sinzinger, J Kaliman, G JoskovicsProstaglandins|September 1, 1982
Radiation induced alterations in rabbit aortic prostacyclin formationH Sinzinger, W Firbas, M CromwellActa Medica Austriaca. Supplement|January 1, 1979
[Physiopathology of prostaglandin I2 synthesis in the human gastrointestinal mucosa]H Sinzinger, K Silberbauer, H SeyfriedActa Medica Austriaca|August 22, 2001
Endothelial dysfunction, atherosclerosis and diabetesC Najemnik, H Sinzinger, H KritzProstaglandins, Leukotrienes, and Essential Fatty Acids|June 28, 2001
Do human platelets express COX-2?R Reiter, U Resch, H SinzingerJournal of Cardiovascular Pharmacology|March 1, 1995
Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapyH Sinzinger, A Keiler, J O'GradyObstetrics and Gynecology|July 1, 1984
Prostacyclin synthesis stimulating plasma factor in pregnancy and puerperiumC Dadak, C Hoche, H SinzingerAmerican Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H SinzingerPageof 71